IPO registrations (S-1, F-1) · Registrants
ABVC BIOPHARMA, INC.
- SEC CIK
- 1173313 · filings on EDGAR ↗
- Former names
- American BriVision (Holding) Corp (2016–2021); METU BRANDS, INC. (2015–2016); Ecology Coatings, Inc. (2008–2015); ECOLOGY COATINGS, INC. (2008–2015); OCIS CORP (2002–2007)
- Registration
- Form S-1, first filed 2009-06-23, last 2024-06-21; 8 initial registrations, 29 amendments
- Outcome
- Final prospectus filed 2020-12-28; declared effective 2019-08-07; withdrawal requested 2012-01-12
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- NV
- Business address
- 44370 OLD WARM SPRINGS BLVD., Fremont, CA 94538
- EIN
- 26-0014658
- Ticker
- ABVC, ECOC (Nasdaq, OTC)
- EDGAR entity type
- operating
- Insiders and CEO pay
- ABVC BIOPHARMA, INC. on the corporate pages
On this site
- Form D issuer: ABVC BIOPHARMA, INC. EXACT (CIK (EXACT))
- SEC filer: ABVC BIOPHARMA, INC. EXACT (CIK (EXACT))
Filings 92
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2009-06-23 | S-1 | S-1 (registration) | ECOLOGY COATINGS, INC. | 0001173313-09-000053 ↗ |
| 2009-09-03 | S-1/A | S-1/A (amendment) | ECOLOGY COATINGS, INC. | 0001173313-09-000086 ↗ |
| 2009-09-10 | S-1/A | S-1/A (amendment) | ECOLOGY COATINGS, INC. | 0001173313-09-000092 ↗ |
| 2009-10-20 | S-1/A | S-1/A (amendment) | ECOLOGY COATINGS, INC. | 0001173313-09-000106 ↗ |
| 2009-11-23 | S-1/A | S-1/A (amendment) | ECOLOGY COATINGS, INC. | 0001173313-09-000118 ↗ |
| 2010-01-12 | S-1/A | S-1/A (amendment) | ECOLOGY COATINGS, INC. | 0001173313-10-000005 ↗ |
| 2010-02-17 | S-1/A | S-1/A (amendment) | ECOLOGY COATINGS, INC. | 0001173313-10-000039 ↗ |
| 2012-01-12 | RW | RW (withdrawal request) | ECOLOGY COATINGS, INC. | 0001173313-12-000004 ↗ |
| 2012-01-18 | RW | RW (withdrawal request) | ECOLOGY COATINGS, INC. | 0001173313-12-000008 ↗ |
| 2016-09-13 | S-1 | S-1 (registration) | American BriVision (Holding) Corp | 0001615774-16-007154 ↗ |
| 2016-11-14 | S-1/A | S-1/A (amendment) | American BriVision (Holding) Corp | 0001615774-16-008325 ↗ |
| 2017-01-12 | S-1/A | S-1/A (amendment) | American BriVision (Holding) Corp | 0001213900-17-000306 ↗ |
| 2017-01-19 | S-1/A | S-1/A (amendment) | American BriVision (Holding) Corp | 0001213900-17-000495 ↗ |
| 2017-05-24 | S-1/A | S-1/A (amendment) | American BriVision (Holding) Corp | 0001213900-17-005824 ↗ |
| 2017-07-17 | S-1/A | S-1/A (amendment) | American BriVision (Holding) Corp | 0001213900-17-007661 ↗ |
| 2017-09-22 | S-1/A | S-1/A (amendment) | American BriVision (Holding) Corp | 0001213900-17-009909 ↗ |
| 2018-06-12 | RW | RW (withdrawal request) | American BriVision (Holding) Corp | 0001213900-18-007531 ↗ |
| 2018-11-14 | S-1 | S-1 (registration) | American BriVision (Holding) Corp | 0001213900-18-015834 ↗ |
| 2019-02-14 | S-1/A | S-1/A (amendment) | American BriVision (Holding) Corp | 0001213900-19-002588 ↗ |
| 2019-06-28 | S-1/A | S-1/A (amendment) | American BriVision (Holding) Corp | 0001213900-19-011793 ↗ |
| 2019-07-24 | S-1/A | S-1/A (amendment) | American BriVision (Holding) Corp | 0001213900-19-013446 ↗ |
| 2019-08-06 | S-1/A | S-1/A (amendment) | American BriVision (Holding) Corp | 0001213900-19-014676 ↗ |
| 2019-08-07 | EFFECT | EFFECT (declared effective) | American BriVision (Holding) Corp | 9999999995-19-001820 ↗ |
| 2020-02-24 | RW | RW (withdrawal request) | American BriVision (Holding) Corp | 0001213900-20-004626 ↗ |
| 2020-11-24 | S-1 | S-1 (registration) | American BriVision (Holding) Corp | 0001213900-20-038891 ↗ |
| 2020-12-15 | S-1/A | S-1/A (amendment) | American BriVision (Holding) Corp | 0001213900-20-042708 ↗ |
| 2020-12-23 | EFFECT | EFFECT (declared effective) | American BriVision (Holding) Corp | 9999999995-20-003654 ↗ |
| 2020-12-28 | 424B4 | 424B4 (final prospectus) | American BriVision (Holding) Corp | 0001213900-20-044501 ↗ |
| 2021-04-08 | S-1 | S-1 (registration) | American BriVision (Holding) Corp | 0001213900-21-020698 ↗ |
| 2021-04-19 | EFFECT | EFFECT (declared effective) | ABVC BIOPHARMA, INC. | 9999999995-21-001476 ↗ |
| 2021-05-11 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-21-025566 ↗ |
| 2021-05-14 | S-1/A | S-1/A (amendment) | ABVC BIOPHARMA, INC. | 0001213900-21-026466 ↗ |
| 2021-06-21 | S-1/A | S-1/A (amendment) | ABVC BIOPHARMA, INC. | 0001213900-21-033326 ↗ |
| 2021-07-21 | S-1/A | S-1/A (amendment) | ABVC BIOPHARMA, INC. | 0001213900-21-037808 ↗ |
| 2021-07-28 | S-1/A | S-1/A (amendment) | ABVC BIOPHARMA, INC. | 0001213900-21-039129 ↗ |
| 2021-07-29 | S-1/A | S-1/A (amendment) | ABVC BIOPHARMA, INC. | 0001213900-21-039247 ↗ |
| 2021-08-02 | EFFECT | EFFECT (declared effective) | ABVC BIOPHARMA, INC. | 9999999995-21-003014 ↗ |
| 2021-08-03 | S-1MEF | S-1MEF (added securities) | ABVC BIOPHARMA, INC. | 0001213900-21-040076 ↗ |
| 2021-08-04 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-21-040290 ↗ |
| 2021-11-29 | EFFECT | EFFECT (declared effective) | ABVC BIOPHARMA, INC. | 9999999995-21-004500 ↗ |
| 2022-06-17 | EFFECT | EFFECT (declared effective) | ABVC BIOPHARMA, INC. | 9999999995-22-001809 ↗ |
| 2022-06-23 | EFFECT | EFFECT (declared effective) | ABVC BIOPHARMA, INC. | 9999999995-22-001851 ↗ |
| 2022-07-11 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-22-038534 ↗ |
| 2022-08-25 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-22-051133 ↗ |
| 2022-11-15 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-22-072724 ↗ |
| 2023-04-24 | S-1 | S-1 (registration) | ABVC BIOPHARMA, INC. | 0001213900-23-032016 ↗ |
| 2023-05-01 | EFFECT | EFFECT (declared effective) | ABVC BIOPHARMA, INC. | 9999999995-23-001122 ↗ |
| 2023-05-01 | EFFECT | EFFECT (declared effective) | ABVC BIOPHARMA, INC. | 9999999995-23-001126 ↗ |
| 2023-05-10 | S-1/A | S-1/A (amendment) | ABVC BIOPHARMA, INC. | 0001213900-23-038161 ↗ |
| 2023-05-22 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-23-041839 ↗ |
| 2023-06-01 | S-1/A | S-1/A (amendment) | ABVC BIOPHARMA, INC. | 0001213900-23-045059 ↗ |
| 2023-06-07 | S-1/A | S-1/A (amendment) | ABVC BIOPHARMA, INC. | 0001213900-23-047063 ↗ |
| 2023-06-08 | S-1/A | S-1/A (amendment) | ABVC BIOPHARMA, INC. | 0001213900-23-047291 ↗ |
| 2023-06-08 | EFFECT | EFFECT (declared effective) | ABVC BIOPHARMA, INC. | 9999999995-23-001683 ↗ |
| 2023-06-12 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-23-048172 ↗ |
| 2023-08-17 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-23-068605 ↗ |
| 2023-08-17 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-23-068606 ↗ |
| 2023-11-17 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-23-088373 ↗ |
| 2023-11-17 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-23-088374 ↗ |
| 2024-01-12 | S-1 | S-1 (registration) | ABVC BIOPHARMA, INC. | 0001213900-24-003415 ↗ |
| 2024-02-09 | S-1/A | S-1/A (amendment) | ABVC BIOPHARMA, INC. | 0001213900-24-012141 ↗ |
| 2024-02-16 | S-1/A | S-1/A (amendment) | ABVC BIOPHARMA, INC. | 0001213900-24-014947 ↗ |
| 2024-03-22 | S-1/A | S-1/A (amendment) | ABVC BIOPHARMA, INC. | 0001213900-24-025197 ↗ |
| 2024-04-01 | EFFECT | EFFECT (declared effective) | ABVC BIOPHARMA, INC. | 9999999995-24-000813 ↗ |
| 2024-04-05 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-24-030778 ↗ |
| 2024-04-30 | EFFECT | EFFECT (declared effective) | ABVC BIOPHARMA, INC. | 9999999995-24-001194 ↗ |
| 2024-05-22 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-24-045843 ↗ |
| 2024-05-22 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-24-045957 ↗ |
| 2024-05-23 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-24-046294 ↗ |
| 2024-06-21 | S-1 | S-1 (registration) | ABVC BIOPHARMA, INC. | 0001213900-24-054857 ↗ |
| 2024-07-01 | EFFECT | EFFECT (declared effective) | ABVC BIOPHARMA, INC. | 9999999995-24-002046 ↗ |
| 2024-07-12 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-24-061016 ↗ |
| 2024-08-01 | EFFECT | EFFECT (declared effective) | ABVC BIOPHARMA, INC. | 9999999995-24-002346 ↗ |
| 2024-08-16 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-24-070270 ↗ |
| 2024-08-16 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-24-070271 ↗ |
| 2024-08-16 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-24-070277 ↗ |
| 2024-10-25 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-24-090651 ↗ |
| 2024-11-15 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-24-099058 ↗ |
| 2024-11-15 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-24-099059 ↗ |
| 2024-11-15 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-24-099061 ↗ |
| 2024-11-15 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-24-099062 ↗ |
| 2025-05-20 | EFFECT | EFFECT (declared effective) | ABVC BIOPHARMA, INC. | 9999999995-25-001660 ↗ |
| 2025-05-20 | EFFECT | EFFECT (declared effective) | ABVC BIOPHARMA, INC. | 9999999995-25-001662 ↗ |
| 2025-08-15 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-25-077473 ↗ |
| 2025-08-15 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-25-077476 ↗ |
| 2025-08-15 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-25-077482 ↗ |
| 2025-08-15 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-25-077487 ↗ |
| 2025-08-15 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-25-077489 ↗ |
| 2025-11-14 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-25-110898 ↗ |
| 2025-11-14 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-25-110900 ↗ |
| 2025-11-14 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-25-110902 ↗ |
| 2025-11-14 | 424B4 | 424B4 (final prospectus) | ABVC BIOPHARMA, INC. | 0001213900-25-110903 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Krotine Frank Thomas | Director,Officer; Officer | CEO, President; COO; COO, President; President & COO | 4 | 2007–2011 | |
| Liebig Robert W | Director | 1 | 2007 | ||
| Ramsey Sally Judith | Director,Officer; Director,TenPercentOwner; Officer | Vice President; VP New Product Development | 4 | 2007–2011 | |
| Stolz Kevin Patrick | Officer | CFO & Controller; Controller; VP & Controller | 5 | 2007–2012 | |
| Stromback Richard Dean | Director,Officer,TenPercentOwner; Director,TenPercentOwner; TenPercentOwner | CEO | 5 | 2007–2010 | |
| Tracy Adam Samuel | Officer | V.P., General Counsel | 1 | 2007 | |
| MORGAN DAVID W | Officer | CFO & Treasurer; Chief Financial Officer | 2 | 2007–2008 | |
| Campion Donald C | Director | 2 | 2007 | ||
| IANNOTTI DANIEL V | Officer | VP, General Counsel & Secretar; VP, General Counsel, Secretary | 7 | 2008–2011 | |
| Crockett Robert G | Officer | Chief Executive Officer | 4 | 2008–2011 | |
| Smith J.B. | Director; Director,TenPercentOwner | 24 | 2008–2010 | ||
| DelMonaco, Jr. Rocco | Director | 2 | 2008–2010 | ||
| Nirta Joseph | Director | 1 | 2010 | ||
| Juliano James | Director; Director,TenPercentOwner | 2 | 2010 | ||
| Orchard James | Director | 1 | 2010 | ||
| Rempinski Daniel | Director | 1 | 2010 | ||
| Lazar Shulamit | Director,Officer,TenPercentOwner | President,Secretary,Treasurer | 1 | 2015 | |
| Jiang Tsang Ming | Director | 1 | 2021 | ||
| Chou Yen-Hsin | Director | 1 | 2021 | ||
| Doong Howard | Officer | Chief Executive Officer | 1 | 2021 | |
| King Chi-Hsin Richard | Officer | Chief Scientific Officer | 1 | 2021 | |
| Jiang Chang-Jen | Director | 1 | 2021 | ||
| Jiang Eugene | Director,Officer | Chairman of the Board & CBO | 1 | 2021 | |
| Jiang Tsung Shann | Director,Officer | CSO and Director | 1 | 2021 | |
| Miao Shin-Yu | Director | 1 | 2021 | ||
| Tseng Shih-Chen | Director | 1 | 2021 | ||
| Odaira Yoshinobu | Director | 1 | 2021 | ||
| Sakamoto Norimi | Director | 1 | 2021 | ||
| An Chihliang | Officer | Chief Financial Officer | 1 | 2022 | |
| Jiang Shuling | Director,TenPercentOwner | 1 | 2022 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-05-28 | ABVC BIOPHARMA, INC. | Biotechnology | $750,000 | $750,000 | 1 | 1 |
| 2023-03-02 | ABVC BIOPHARMA, INC. | Biotechnology | $3,704,167 | $3,175,000 | 1 | 1 |
| 2018-07-27 | American BriVision (Holding) Corp | Biotechnology | $1,100,000 | $550,000 | 2 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.